维普中文期刊产品整合服务
79篇 您的检索式:作者名="Carbone DP"
    题名 作者 年代 出处 被引量
1Defective function of langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors显示文摘ISHIDA T OYAMA T CARBONE DP 1998J Immunol1998,161,:1
2Immunologic dysfunction in cancer 显示文摘Kavanangh DY Carbone DP 1996Hematol Oncol Clin North Am1996,10,4:1
3VEGF as a mediator of tumor-associ- ated immunodeficiency显示文摘Ohm JE Carbone DP 2001Immunologic research2001,23,23:1
4Genomie and proteomic profiling of lung cancers:Lung cancer classification in the age of targeted therapy显示文摘MEYERSON M CARBONE DP 2005J Clin Oncol2005,23,:1
5Tumor-host immue interactions and dendritic cell dysfunction 显示文摘Yang L Carbone DP 2004Adv Cancer Res2004,92,:1
6A phase lI study of celecoxib in combination with paclitaxel,carboplatin, and radiotherapy for patients with inoperable stage 11I A/B non-small cell lung cancer 显示文摘Mutter R Lu B Carbone DP 2009Clin Cancer Res2009,5,6:1
7Immune dysfunction in cancer patients显示文摘Carbone JE Ohm DP 2002Oncology(Huntington)2002,161,:1
8VEGF as a mediator of tumor-associated immunodeficiency显示文摘Ohm JE Carbone DP 2001Immunol Res2001,23,23:1
9VEGF as a mediator of tumor-associated immunodeficiency显示文摘Ohm JE Carbone DP 2001Immunol Res2001,23,23:1
10Mechanisms of and strategies for overcoming resistance to anti-vascular endothelial growth factor therapy in non-small cell lung cancer 显示文摘Huang Y Carbone DP 2015Bioehim Biophys Aeta2015,1855,2:1
11Defective func-tion of Langerhans cell in tumor-bearing animals isthe result of defective maturation from hemopoieticprogenitors显示文摘Ishida T Oyama T Carbone DP 1998J Immunol1998,161,:1
12VEGF as a mediator of tumor-associated immunodeficiency显示文摘Ohm JE Carbone DP 2001Immunol Res2001,23,23:1
13The bialogy of lung cancer显示文摘Carbone DP 1997Semin Oncol1997,24,4:1
14Paranasal sinus mucocele显示文摘Capra GG Carbone PN Mullin DP 0,,03:1
15The biology of lung cancer显示文摘Carbone DP 1997Semin Oncol1997,24,:1
16A phase II study of celecoxib in combi- nation with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage III A/B non-small cell 显示文摘Mutter R Lu B Carbone DP 2009Lung Cancer2009,15,6:1
17Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition显示文摘AMORINO GP FREEMAN ML CARBONE DP 1999Radiat Oncol Biol Phys1999,44,2:1
18VeriStrat classifierfor survival and time to progression in non-small cell lung cancer(NSCLC) patients treated with erlotinib and bevacizumab 显示文摘Carbone DP Salmon JS Billheimer D 2010Lung Cancer2010,69,3:1
19Tumor-host immune interactions and dendritic cell dysfunction显示文摘Yang L Carbone DP 2004Adv Cancer Res2004,92,:1
20Tumor-host immune interactions and dendritic cell dysfunction显示文摘Yang L Carbone DP 2004Adv Cancer Res2004,92,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费